CVAC•benzinga•
CureVac (CVAC) Stock Rises After Q1 Update, Oncology Pipeline Gains Traction
Summary
CureVac stock surged after reporting Q1 2025 results and a positive pipeline update. The biotech firm narrowed its operating loss, and cash is expected to fund operations through 2028.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 20, 2025 by benzinga